Issue 43, 2013

Novel self-assembled lithocholic acidnanoparticles for drug delivery in cancer

Abstract

Novel versatile self-assembled nanoparticles were developed from biocompatible, biodegradable lithocholic acid derivatives. These nanoparticles can incorporate different cytotoxic drugs (paclitaxel and doxorubicin) and PI3K signalling inhibitor (PI103). Drugs were released from the nanoparticles in a slow, sustained manner at acidic pH. The drug loaded nanoparticles were internalized through lysosomal compartments and induced cell death in HeLa cervical cancer cells.

Graphical abstract: Novel self-assembled lithocholic acid nanoparticles for drug delivery in cancer

Supplementary files

Article information

Article type
Communication
Submitted
15 Jun 2013
Accepted
15 Aug 2013
First published
16 Aug 2013

RSC Adv., 2013,3, 19760-19764

Novel self-assembled lithocholic acid nanoparticles for drug delivery in cancer

S. Patil, S. Patil, S. Gawali, S. Shende, S. Jadhav and S. Basu, RSC Adv., 2013, 3, 19760 DOI: 10.1039/C3RA42994F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements